XPH vs. XHS
XPH (SPDR S&P Pharmaceuticals ETF) and XHS (SPDR S&P Health Care Services ETF) are both Health & Biotech Equities funds from State Street - XPH tracks the S&P Pharmaceuticals Select Industry Index while XHS tracks the S&P Health Care Services Select Industry Index. Both are passively managed. Over the past 10 years, XPH returned 3.44%/yr vs 7.46%/yr for XHS. A 0.65 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.
Performance
XPH vs. XHS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 0.66% return, which is significantly lower than XHS's 6.32% return. Over the past 10 years, XPH has underperformed XHS with an annualized return of 3.44%, while XHS has yielded a comparatively higher 7.46% annualized return.
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
XHS
- 1D
- 0.28%
- 1M
- 2.77%
- YTD
- 6.32%
- 6M
- 5.39%
- 1Y
- 16.58%
- 3Y*
- 8.47%
- 5Y*
- 0.44%
- 10Y*
- 7.46%
XPH vs. XHS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
XHS SPDR S&P Health Care Services ETF | 6.32% | 18.83% | 1.76% | 5.15% | -19.87% | 9.76% | 33.66% | 18.81% | 1.96% | 17.65% |
Correlation
The correlation between XPH and XHS is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.66 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2011 | 0.65 |
Over the past year, the correlation between XPH and XHS has dropped to 0.43 - well below their long-term average of 0.65, suggesting their price drivers have been diverging.
XPH vs. XHS - Sectors Allocation Comparison
Sectors
XPH
XHS
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XPH
XHS
Basic Materials
XPH
-
XHS
-
Communication Services
XPH
-
XHS
-
Consumer Cyclical
XPH
-
XHS
-
Consumer Defensive
XPH
-
XHS
-
Energy
XPH
-
XHS
-
Financial Services
XPH
-
XHS
Industrials
XPH
-
XHS
-
Real Estate
XPH
-
XHS
-
Technology
XPH
-
XHS
-
Utilities
XPH
-
XHS
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. XHS — Risk / Return Rank
XPH
XHS
XPH vs. XHS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | XHS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.82 | ||
| Sortino ratioReturn per unit of downside risk | +1.12 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.18 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 3.19 | 1.39 | +1.80 |
| Martin ratioReturn relative to average drawdown | 11.37 | 3.83 | +7.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XPH | XHS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | 0.95 | +0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | 0.02 | +0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.33 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.57 | -0.18 |
Drawdowns
XPH vs. XHS - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, which is greater than XHS's maximum drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for XPH and XHS.
Loading charts...
Drawdown Indicators
| XPH | XHS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -39.32% | -8.71% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -11.99% | +0.02% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -17.81% | -5.76% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -32.62% | +0.99% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -39.32% | +3.35% |
Current DrawdownCurrent decline from peak | -7.22% | -1.78% | -5.44% |
Average DrawdownAverage peak-to-trough decline | -17.25% | -10.20% | -7.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.35% | 4.33% | -0.98% |
Volatility
XPH vs. XHS - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.03% compared to SPDR S&P Health Care Services ETF (XHS) at 4.80%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than XHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | XHS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.03% | 4.80% | +2.23% |
Volatility (6M)Calculated over the trailing 6-month period | 16.77% | 11.86% | +4.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.52% | 17.56% | +3.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.84% | 21.10% | -0.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.10% | 22.40% | -0.30% |
XPH vs. XHS - Expense Ratio Comparison
Both XPH and XHS have an expense ratio of 0.35%.
Dividends
XPH vs. XHS - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.66%, more than XHS's 0.25% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XHS SPDR S&P Health Care Services ETF | 0.25% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and XHS have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.03%) compared to XHS (4.80%). In terms of maximum drawdown, XPH dropped -48.03% vs XHS's -39.32%.
On 10-year performance, XHS leads with 7.46% vs 3.44% for XPH. Both ETFs have the same 0.35% expense ratio. On volatility, XHS has been the lower-risk option at 4.80%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XHS has performed better with a 7.46% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH and XHS have the same expense ratio: 0.35% per year.
XPH has the higher dividend yield at 0.66%, compared with 0.25% for XHS.
XPH tracks S&P Pharmaceuticals Select Industry Index, while XHS tracks S&P Health Care Services Select Industry Index.
XPH currently has the higher Sharpe Ratio (1.77 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and XHS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer